Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trials
- 1 May 2007
- Vol. 25 (18) , 3517-3523
- https://doi.org/10.1016/j.vaccine.2007.02.078
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- T cell surface redox levels determine T cell reactivity and arthritis susceptibilityProceedings of the National Academy of Sciences, 2006
- Antibody‐Mediated Regulation of the Immune ResponseScandinavian Journal of Immunology, 2006
- Immunobiology of CD28 expression on human neutrophils. I. CD28 regulates neutrophil migration by modulating CXCR-1 expressionEuropean Journal of Immunology, 2001
- Accessibility of cell surface thiols in human lymphocytes is altered by ionophores or OKT-3 antibodyBiochemical and Biophysical Research Communications, 1986
- Two genetically different MU-NANA neuraminidases in human leucocytesBiochemical and Biophysical Research Communications, 1983
- Stimulation of sialidase activity during cell differentiation of human promyelocytic leukemia cell line HL-60Biochemical and Biophysical Research Communications, 1982
- Glycoproteins Containing Peanu t‐Agglutinin Receptors from Human‐Peripheral‐ Blood T‐Lymphocyte Plasma MembranesEuropean Journal of Biochemistry, 1981
- T and B Lymphocytes: Striking Differences in Surface MembranesBMJ, 1974
- Sulphydryl Groups on the Surface of Intact Ehrlich Ascites Tumour Cells, Human Blood Platelets and LymphocytesNature, 1969
- Murine ascites tumour cells and lymphocytes: Effect of lysolecithin, organic mercurials and an anti-tumoral agent on the cell membrane permeabilityPublished by Elsevier ,1969